BeiGene – A Star in China’s Booming Biotech Market

BeiGene 1-Year Chart_2018BeiGene Ltd (BGNE) is a commercial-stage, research-based biopharmaceutical company and one of the leading players in China’s booming biotech market. The company develops and markets next-generation molecularly targeted and immuno-oncology drugs for cancer treatment.

Please login or purchase a membership to view full text.

Leave a Reply